Literature DB >> 18780858

Cancer gene therapy steadily advances.

Vicki Brower.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18780858     DOI: 10.1093/jnci/djn335

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences.

Authors:  Aya Mizrahi; Abraham Hochberg; Smadar Amiur; Jennifer Gallula; Imad Matouk; Tatiana Birman; Tally Levy; Sorin Ladimir; Patricia Ohana
Journal:  Int J Clin Exp Med       Date:  2010-09-21

2.  The attitude of oncology physicians and nurses to the acceptance of new drugs for gene therapy.

Authors:  Zi-ming Liu; Chang Liu; Jun-ying Li; Chun-hua Yu; Yu Jiang
Journal:  J Cancer Educ       Date:  2011-06       Impact factor: 2.037

Review 3.  Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors:  April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

4.  Lipid encapsulation of cationic polymers in hybrid nanocarriers reduces their non-specific toxicity to breast epithelial cells.

Authors:  Hui Yi Xue; Mayuri Narvikar; Juan-Bao Zhao; Ho Lun Wong
Journal:  Pharm Res       Date:  2012-11-08       Impact factor: 4.200

5.  Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth.

Authors:  Shian-Ying Sung; Junn-Liang Chang; Kuan-Chou Chen; Shauh-Der Yeh; Yun-Ru Liu; Yen-Hao Su; Chia-Yen Hsueh; Leland W K Chung; Chia-Ling Hsieh
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.